Is HCV drug resistance an issue? | Jürgen Rockstroh, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2016

Treatment of Hepatitis C: an Asian-Pacific perspective | Dr. Sang Hoon Ahn

Asian Conference on Hepatitis and AIDS (ACHA) 2016

RNAi therapeutics for chronic HBV - Clinical data | Dr. Man-Fung Yuen

Asian Conference on Hepatitis and AIDS (ACHA) 2016

RNAi therapeutics for chronic HBV - Animal models | Dr. Bruce D. Given

Asian Conference on Hepatitis and AIDS (ACHA) 2016

New Treatments/Targets in HBV | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)

Asian Conference on Hepatitis and AIDS (ACHA) 2016

Hepatitis B immunological pathogenesis and immunological assessment | Dr. Chao Wu

Asian Conference on Hepatitis and AIDS (ACHA) 2016

Eradication of HIV | Bonaventura Clotet, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2016

Selecting the best ART for each patient | Corklin Steinhart, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2016

The study of anti HIV/AIDS in Nanjing | Dr. Wei Zhao

Asian Conference on Hepatitis and AIDS (ACHA) 2016

Real life cases | Elise Smolders

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Specific Complex Interactions (mechanic presentation) | David Burger, PharmD, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Backing up clinical data with modelling | Marco Siccardi, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Back-terial co-infections | Mohammed Lamorde, FRCP, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

The ‘Back Side’ of Compartments | Saye Khoo, MD, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Will we see the Back of DDIs? | Catia Marzolini, PharmD, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Pharmacogenetics - Back to reality | Andrew Owen, BSS, MSC, PhD, FSB

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Looking Backwards: Hormonal Contraception and ARTv | Kimberly Scarsi, PharmD, MS, FCCP

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Janssen - Rilpivirine | Herta Crauwels, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Target Concentrations | Angela Kashuba, PharmD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

The FDA Perspective on Hepatitis C Drug Resistance | Patrick Harrington, PHD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Other Viruses: using Wolbachia to interrupt transmission of viral infections such as Dengue, Chikungunya and Zika | Steven Kern, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2018

Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2018

Eradication of HIV- Bonaventura Clotet, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2018